Breakout Clearing Overnight Treatment

Manufacturer: Dermalogica, Inc. | Cosway | Diamond Wipes
Effective date: 2014-02-05
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 22:38:22

Label at a glance#

ProductBreakout Clearing Overnight Treatment

Active ingredientSalicylic Acid

Label structure9 sections

Dosage and administration

Clean the skin thoroughly before applying. Cover the affected area with a thin layer at night. Because too much drying of the skin may occur, start with 1 application daily at night, and if bothersome dryness or peeling occurs, reduce application to 2 to 3 times per week.

Storage and handling

Protect this product from excessive heat and direct sun.

Contacts and useful links#

PhoneLabel contact1-800-831-5150

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid (2.0%).

Indications

INDICATIONS & USAGE SECTION

OTC - PURPOSE SECTION

for the treatment of acne

Warnings

WARNINGS SECTION

For external use only.

Do not use

OTC - DO NOT USE SECTION

in or near eyes. If contact occurs, flush thoroughly with water

When using this product

OTC - WHEN USING SECTION

apply to affected areas only
Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Clean the skin thoroughly before applying.
Cover the affected area with a thin layer at night.
Because too much drying of the skin may occur, start with 1 application daily at night, and if bothersome dryness or peeling occurs, reduce application to 2 to 3 times per week.

Other information

STORAGE AND HANDLING SECTION

Protect this product from excessive heat and direct sun.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water/Aqua/Eau, Isohexadecane, PEG-32, Glyceryl Stearate, Dimethicone, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Cetearyl Alcohol, Butylene Glycol, C12-15 Alkyl Benzoate, Stearic Acid, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Spiraea Ulmaria Extract, Camphor, Lavandula Angustifolia (Lavender) Flower Extract, Camellia Sinensis Leaf Extract, Glycyrrhiza Glabra Rhizome/Root, Porphyra Umbilicalis Extract, Cucumis Sativus (Cucumber) Fruit Extract, Sodium Hyaluronate Crosspolymer, Caprylic/ Capric Triglyceride, Zinc Acetate, Potassium Jojobate, Propanediol, PVM/ MA Copolymer, Ceteareth-20, Xanthan Gum, Polysorbate 60, Jojoba Alcohol, Sodium Hydroxide, Ethylhexylglycerin, Phenoxyethanol.

Questions or comments

OTC - QUESTIONS SECTION

Call toll free 1-800-831-5150 in the US

PRINCIPAL DISPLAY PANEL - 59 mL Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

dermalogica^®
clear

2%
salicylic
acid

Breakout Clearing
Overnight
Treatment

2.0 US FL OZ / 59 mL e

PRINCIPAL DISPLAY PANEL - 59 mL Tube Carton

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
190f2a5b-bbc8-65c7-fcb0-97891307b917	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68479-313-00	2020-01-31	C162847	48780-1	9d75b9d0-a327-f424-e053-dadaa90a57ce	Breakout Clearing Overnight Treatment
68479-313-01	2020-01-31	C162847	48780-1	9d75b9d0-a327-f424-e053-dadaa90a57ce	Breakout Clearing Overnight Treatment
68479-313-02	2020-01-31	C162847	48780-1	9d75b9d0-a327-f424-e053-dadaa90a57ce	Breakout Clearing Overnight Treatment

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
68479-313-00	Breakout Clearing Overnight Treatment	2 mL in 1 POUCH	LOTION	2	1
68479-313-01	Breakout Clearing Overnight Treatment	14 mL in 1 TUBE	LOTION	14	1
68479-313-02	Breakout Clearing Overnight Treatment	1 in 1 CARTON	LOTION	1	1
68479-313-02	Breakout Clearing Overnight Treatment	59 mL in 1 TUBE	LOTION	59	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68479-313	BREAKOUT CLEARING OVERNIGHT TREATMENT (SALICYLIC ACID) LOTION [DERMALOGICA, INC.]	1	Legacy NDC, 4 package rows	20140213_b8af71fd-ecf3-4bb1-9b57-e11dfe703b6c.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Salicylic Acid	ACTIVE INGREDIENT	O414PZ4LPZ	1
Salicylic Acid	ACTIVE MOIETY	O414PZ4LPZ	1
Alkyl (C12-15) Benzoate	INACTIVE INGREDIENT	A9EJ3J61HQ	1
Butylene Glycol	INACTIVE INGREDIENT	3XUS85K0RA	1
CAMPHOR (SYNTHETIC)	INACTIVE INGREDIENT	5TJD82A1ET	1
Cetostearyl Alcohol	INACTIVE INGREDIENT	2DMT128M1S	1
Cucumber	INACTIVE INGREDIENT	YY7C30VXJT	1
Dimethicone	INACTIVE INGREDIENT	92RU3N3Y1O	1
Ethylhexylglycerin	INACTIVE INGREDIENT	147D247K3P	1
FILIPENDULA ULMARIA ROOT	INACTIVE INGREDIENT	997724QNDS	1
Glyceryl Monostearate	INACTIVE INGREDIENT	230OU9XXE4	1
GLYCYRRHIZA GLABRA	INACTIVE INGREDIENT	2788Z9758H	1
Green Tea Leaf	INACTIVE INGREDIENT	W2ZU1RY8B0	1
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%)	INACTIVE INGREDIENT	86FQE96TZ4	1
Isohexadecane	INACTIVE INGREDIENT	918X1OUF1E	1
Lavandula Angustifolia Flower	INACTIVE INGREDIENT	19AH1RAF4M	1
Medium-Chain Triglycerides	INACTIVE INGREDIENT	C9H2L21V7U	1
Phenoxyethanol	INACTIVE INGREDIENT	HIE492ZZ3T	1
POLYETHYLENE GLYCOL 1500	INACTIVE INGREDIENT	1212Z7S33A	1
Polyoxyl 20 Cetostearyl Ether	INACTIVE INGREDIENT	YRC528SWUY	1
Polysorbate 60	INACTIVE INGREDIENT	CAL22UVI4M	1
Porphyra Umbilicalis	INACTIVE INGREDIENT	14AN0J70WO	1
Propanediol	INACTIVE INGREDIENT	5965N8W85T	1
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	1
Stearic Acid	INACTIVE INGREDIENT	4ELV7Z65AP	1
Tea Tree Oil	INACTIVE INGREDIENT	VIF565UC2G	1
Water	INACTIVE INGREDIENT	059QF0KO0R	1
Xanthan Gum	INACTIVE INGREDIENT	TTV12P4NEE	1
Zinc Acetate	INACTIVE INGREDIENT	FM5526K07A	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 29 matching rows.

Breakout Clearing Overnight Treatment
Salicylic Acid
Water
Isohexadecane
POLYETHYLENE GLYCOL 1500
Glyceryl Monostearate
Dimethicone
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%)
Cetostearyl Alcohol
Butylene Glycol
Alkyl (C12-15) Benzoate
Stearic Acid
Tea Tree Oil
FILIPENDULA ULMARIA ROOT
CAMPHOR (SYNTHETIC)
Lavandula Angustifolia Flower
Green Tea Leaf
GLYCYRRHIZA GLABRA
Porphyra Umbilicalis
Cucumber
Medium-Chain Triglycerides
Zinc Acetate
Propanediol
Polyoxyl 20 Cetostearyl Ether
Xanthan Gum
Polysorbate 60
Sodium Hydroxide
Ethylhexylglycerin
Phenoxyethanol

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
68479-313	68479-313-02, 68479-313-01, 68479-313-00

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 28 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Salicylic Acid	O414PZ4LPZ	ACTIB
Water	059QF0KO0R	IACT
Isohexadecane	918X1OUF1E	IACT
POLYETHYLENE GLYCOL 1500	1212Z7S33A	IACT
Glyceryl Monostearate	230OU9XXE4	IACT
Dimethicone	92RU3N3Y1O	IACT
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%)	86FQE96TZ4	IACT
Cetostearyl Alcohol	2DMT128M1S	IACT
Butylene Glycol	3XUS85K0RA	IACT
Alkyl (C12-15) Benzoate	A9EJ3J61HQ	IACT
Stearic Acid	4ELV7Z65AP	IACT
Tea Tree Oil	VIF565UC2G	IACT
FILIPENDULA ULMARIA ROOT	997724QNDS	IACT
CAMPHOR (SYNTHETIC)	5TJD82A1ET	IACT
Lavandula Angustifolia Flower	19AH1RAF4M	IACT
Green Tea Leaf	W2ZU1RY8B0	IACT
GLYCYRRHIZA GLABRA	2788Z9758H	IACT
Porphyra Umbilicalis	14AN0J70WO	IACT
Cucumber	YY7C30VXJT	IACT
Medium-Chain Triglycerides	C9H2L21V7U	IACT
Zinc Acetate	FM5526K07A	IACT
Propanediol	5965N8W85T	IACT
Polyoxyl 20 Cetostearyl Ether	YRC528SWUY	IACT
Xanthan Gum	TTV12P4NEE	IACT
Polysorbate 60	CAL22UVI4M	IACT
Sodium Hydroxide	55X04QC32I	IACT
Ethylhexylglycerin	147D247K3P	IACT
Phenoxyethanol	HIE492ZZ3T	IACT

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 6 · 316 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / PARENTERAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	TABLET, ORALLY DISINTEGRATING / ORAL		1 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
Medium-Chain Triglycerides	MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	TABLET, ORALLY DISINTEGRATING / ORAL		1 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	MOUTHWASH / BUCCAL	2 mg/1ml		Exact identifier — unii candidate 174 equally ranked IID candidates
Cetostearyl Alcohol	CETOSTEARYL ALCOHOL	2DMT128M1S	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 9 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	GEL, METERED / TRANSDERMAL		350 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / ENDOTRACHEAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Xanthan Gum	XANTHAN GUM	TTV12P4NEE	TABLET, FILM COATED / ORAL	0.08 mg		Exact identifier — unii candidate 29 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / INTRASYNOVIAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / PARENTERAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	OINTMENT, AUGMENTED / TOPICAL	0.11 %w/w		Exact identifier — unii candidate 174 equally ranked IID candidates
Glyceryl Monostearate	GLYCERYL MONOSTEARATE	230OU9XXE4	CAPSULE, EXTENDED RELEASE / ORAL	32.4 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	PASTE / DENTAL	0.6 %w/w		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	LIQUID / INTRAMUSCULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Polyoxyl 20 Cetostearyl Ether	POLYOXYL 20 CETOSTEARYL ETHER	YRC528SWUY	SUSPENSION / ORAL		20 mg	Exact identifier — unii candidate 7 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	ENEMA / RECTAL	0.44 %v/v		Exact identifier — unii candidate 174 equally ranked IID candidates
Stearic Acid	STEARIC ACID	4ELV7Z65AP	SOAP / TOPICAL	6 %w/w		Exact identifier — unii candidate 26 equally ranked IID candidates
Glyceryl Monostearate	GLYCERYL MONOSTEARATE	230OU9XXE4	SUSPENSION / AURICULAR (OTIC)	0.5 %w/v		Exact identifier — unii candidate 21 equally ranked IID candidates
Glyceryl Monostearate	GLYCERYL MONOSTEARATE	230OU9XXE4	GRANULE, FOR SUSPENSION / ORAL		4 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / EXTRACORPOREAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Stearic Acid	STEARIC ACID	4ELV7Z65AP	CAPSULE, EXTENDED RELEASE / ORAL		64 mg	Exact identifier — unii candidate 26 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SWAB / TOPICAL	0.01 %w/w		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	136.55 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	CREAM / TOPICAL		69 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
Butylene Glycol	BUTYLENE GLYCOL	3XUS85K0RA	SYSTEM / TOPICAL		1400 mg	Exact identifier — unii candidate 2 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / INTRAMUSCULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR	5.4 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
Stearic Acid	STEARIC ACID	4ELV7Z65AP	LOTION / TOPICAL		80 mg	Exact identifier — unii candidate 26 equally ranked IID candidates
Stearic Acid	STEARIC ACID	4ELV7Z65AP	EMULSION / ORAL	NA		Exact identifier — unii candidate 26 equally ranked IID candidates
Glyceryl Monostearate	GLYCERYL MONOSTEARATE	230OU9XXE4	SUPPOSITORY / RECTAL	35 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
POLYETHYLENE GLYCOL 1500	POLYETHYLENE GLYCOL 1600	1212Z7S33A	SUPPOSITORY / RECTAL	0.3 mg/mg		Exact identifier — unii candidate 6 equally ranked IID candidates
Cetostearyl Alcohol	CETOSTEARYL ALCOHOL	2DMT128M1S	AEROSOL, FOAM / TOPICAL		21 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	LIQUID / ORAL	2 mg/5ml		Exact identifier — unii candidate 174 equally ranked IID candidates
Glyceryl Monostearate	GLYCERYL MONOSTEARATE	230OU9XXE4	TABLET, EXTENDED RELEASE / ORAL		529 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
Medium-Chain Triglycerides	MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	OINTMENT / TOPICAL	20 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / INTRAVASCULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION / ENDOTRACHEAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Phenoxyethanol	PHENOXYETHANOL	HIE492ZZ3T	LOTION / TOPICAL	1 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	GEL / TOPICAL		70 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	JELLY / TOPICAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Glyceryl Monostearate	GLYCERYL MONOSTEARATE	230OU9XXE4	TABLET, CHEWABLE / ORAL		1 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
Zinc Acetate	ZINC ACETATE	FM5526K07A	SWAB / TOPICAL	NA		Exact identifier — unii candidate 3 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / RECTAL	NA		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / INTRA-ARTICULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Stearic Acid	STEARIC ACID	4ELV7Z65AP	TABLET, EXTENDED RELEASE / ORAL		200 mg	Exact identifier — unii candidate 26 equally ranked IID candidates
Glyceryl Monostearate	GLYCERYL MONOSTEARATE	230OU9XXE4	OINTMENT / TOPICAL	5 %w/w		Exact identifier — unii candidate 21 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, EMULSION / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Phenoxyethanol	PHENOXYETHANOL	HIE492ZZ3T	CREAM, AUGMENTED / TOPICAL		10 mg	Exact identifier — unii candidate 6 equally ranked IID candidates
Xanthan Gum	XANTHAN GUM	TTV12P4NEE	TABLET, EXTENDED RELEASE / ORAL		528 mg	Exact identifier — unii candidate 29 equally ranked IID candidates
Xanthan Gum	XANTHAN GUM	TTV12P4NEE	SOLUTION / ORAL		84 mg	Exact identifier — unii candidate 29 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRACAUDAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SHAMPOO / TOPICAL		3 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
Medium-Chain Triglycerides	MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	GEL / TOPICAL		12 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	FILM, SOLUBLE / BUCCAL		5 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
Medium-Chain Triglycerides	MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	SOLUTION / ORAL		5566 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
Cetostearyl Alcohol	CETOSTEARYL ALCOHOL	2DMT128M1S	CREAM / VAGINAL		6 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
CAMPHOR (SYNTHETIC)	CAMPHOR (SYNTHETIC)	5TJD82A1ET	DROPS / OPHTHALMIC	NA		Exact identifier — unii candidate 2 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION, EXTENDED RELEASE / INTRADERMAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / INTRAVENOUS		78 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
Xanthan Gum	XANTHAN GUM	TTV12P4NEE	GEL / TOPICAL		58 mg	Exact identifier — unii candidate 29 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
1278f223-284b-4de2-a570-b7fb0394aa41			b8af71fd-ecf3-4bb1-9b57-e11dfe703b6c	2014-02-05	Warnings	Exact identifier spl id: 1278f223-284b-4de2-a570-b7fb0394aa41 spl set id: b8af71fd-ecf3-4bb1-9b57-e11dfe703b6c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.